Iriyama N, Iwanaga E, Kimura Y, Watanabe N, et al. Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group. Int J Hematol 2024 Apr 8. doi: 10.1007/s12185-024-03758.
PMID: 38587692